The need for an effective screening program
Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) infections represent a critical threat to public health.
- Conventional culture-based screening methods require sample incubation which can delay the implementation of infection control measures.
- More general infection control measures that apply to all patients may provide increased opportunity for transmission.
- Active surveillance to identify MRSA/SA carriers is helping to mitigate the potential consequences of disease, providing relief to patients and health care institutions facing the challenges of escalating costs.
The cobas® MRSA/SA Test for use on the cobas® 4800 System uses a single nasal swab specimen to detect both MRSA and SA targets in a single sample run to deliver high quality results in a matter of hours.